Medication Adherence in Children with Asthma

Paddy McCrossan1, Michael D Shields2, James C McElnay3

  • 1Paediatric Respiratory Medicine, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland.

PubMed

Insights

Poor adherence to asthma action plans is common in children, impacting quality of life and increasing the risk of severe attacks. Improving adherence to preventer medication is crucial for better asthma control.

Area of Science:

  • Pediatric Pulmonology
  • Public Health

Background:

  • Childhood asthma is a prevalent chronic condition with significant impacts on quality of life and risk of fatal attacks.
  • Personalized asthma action plans (PAAPs), including inhaled corticosteroids, are key to effective asthma management.

Purpose of the Study:

  • To investigate medication adherence in pediatric asthma patients.
  • To answer key questions regarding adherence: definition, prevalence, barriers, impact on outcomes, and improvement strategies.

Main Methods:

  • Systematic review of recent evidence.
  • Analysis of data addressing five core questions on asthma medication adherence in children.

Main Results:

  • Evidence indicates suboptimal adherence to preventer medications in children with asthma.
  • Identified numerous barriers contributing to poor adherence.
  • Good adherence is linked to improved asthma outcomes.

Conclusions:

  • Addressing barriers and implementing strategies to improve adherence are essential for effective pediatric asthma management.
  • Enhanced adherence to personalized asthma action plans can reduce symptoms and prevent severe exacerbations.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
256
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
297
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294